News & Events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

Molecure to Host Virtual R&D Day on 7th December 2022

14 November 2022

Molecure Third Quarter 2022 Pipeline Highlights and Financial Results

31 October 2022

Molecure reports continued pipeline momentum for 6 months ended 30th June 2022

29 September 2022

Molecure announces filing of Clinical Trial Application with Polish regulator for OATD-02, a novel dual arginase inhibitor being developed for the treatment of cancer

11 August 2022

Molecure to regain worldwide rights to dual chitinase inhibitor OATD-01

23 June 2022

OncoArendi Therapeutics Reports Continued Strategic and Operational Momentum for 12 Months ended 31 December 2021

25 March 2022

Sign up for the latest News & Events

Events & Presentations

ERS – 9-13 September 2017 Milan

1 September 2017

BIO USA – San Diego 19-22 June 2017

1 June 2017

ATS – Washington 19-24 May 2017

1 May 2017
This site is registered on wpml.org as a development site.